Comparison of Different Up-dosing Schedules With Osiris

Clinical trial NCT01240954 · TERMINATED

Trial details

NCT number: NCT01240954
Sponsor: ALK-Abelló A/S
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Rhinitis

Start date: 2010-12-01
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.